Listing & Compliance Notices

Trinity Place Holdings Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

“January 4, 2024, the Company received a deficiency letter (the “ January Deficiency Letter ”) from the NYSE American advising the Company that the NYSE American had determined that the Company’s securities had been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the Guide, the Company’s continued listing is predicated on it effecting a reverse stock split of its shares of Common Stock or otherwise demonstrating sustained price improvement by no later than July 4, 2024. The January Deficiency Letter states that, as a result of the forego”

GAXOS.AI INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 9, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2) and is not eligible for a second 180 day period because the Company does not comply with the minimum stockholders’ equity initial listing requirement for The Nasdaq Capital Market (the “Delisting Determination”). Further, unless the Company requests an appeal of the Delisting Determination to a Hearings Panel (the “Panel”), the Company’s securities will be scheduled for delisting from the Nasdaq Capital Market and will be suspended at the opening of business on January 18, 2024, and”

Collective Audience, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).

“December 22, 2023, from the Nasdaq Stock Market (“Nasdaq”) indicating that (i) for the preceding 30 consecutive business days, the market value of the Company’s listed securities (“MVLS”) did not maintain a minimum market value of $50,000,000 (the “Minimum MVLS Requirement”) as required by Nasdaq Listing Rule 5450(b)(2)(A), and (ii) for the preceding 30 consecutive business days, the market value of the Company’s publicly held shares (“MVPHS”) did not maintain a minimum market value of $15,000,000 (the “Minimum MVPHS Requirement”) as required by Nasdaq Listing Rule 5450(b)(2)(C). In accordance”

Bannix Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“January 9, 2024, Bannix Acquisition Corp. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 23, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal y”

Northern Star Investment Corp. II received a nyse_american noncompliance notice notice regarding audit committee.

“January 5, 2023, the Company received a notice of non-compliance from the staff of the NYSE American Market (the “Exchange”) indicating that the Company was noncompliant with the continued listing standards set forth in Sections 803B(2)(c) and 803B(2)(a)(iii) of the NYSE American Company Guide (the “Company Guide”), since its audit committee is no longer comprised of at least two independent members and does not have at least one member of the audit committee who is financially sophisticated (the “NYSE Notice”). The NYSE Notice stated that pursuant to Section 803(B)(6)(b) of the Company Guide”

Reborn Coffee, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(2)).

“ceived has no immediate effect on the continued listing of the Company’s common stock on Nasdaq. Nasdaq has previously issued notification letters to the Company for failure to comply with its listing rules. Nasdaq has indicated that the Company has fallen out of compliance with Nasdaq Listing Rule 5550(a)(2) concerning the $1.00 minimum bid price listing standard as previously disclosed by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on May 2, 2023. Nasdaq has also indicated that the Company has failed to comply with Nasdaq Listing Ru”

Reborn Coffee, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(2), 5550(b)(1)).

“ceived has no immediate effect on the continued listing of the Company’s common stock on Nasdaq. Nasdaq has previously issued notification letters to the Company for failure to comply with its listing rules. Nasdaq has indicated that the Company has fallen out of compliance with Nasdaq Listing Rule 5550(a)(2) concerning the $1.00 minimum bid price listing standard as previously disclosed by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on May 2, 2023. Nasdaq has also indicated that the Company has failed to comply with Nasdaq Listing Ru”

Chicken Soup for the Soul Entertainment, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 28, 2023, the Company previously received written notice (the “ Initial Notice ”) from Nasdaq indicating that the Company was not in compliance with the Rules because for the prior 30 consecutive business days (through September 21, 2023), the closing bid price of the Company’s Class A Common Stock, $0.0001 par value per share (“common stock”) had been below the minimum of $1 per share required for continued listing on the Nasdaq under Nasdaq Rule 5550(a)(2). The Notice stated that the Company would be afforded 180 calendar days (until March 20, 2024) to regain compliance. In order t”

Chicken Soup for the Soul Entertainment, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(a)(2)).

“Rules because for the prior 30 consecutive business days (through September 21, 2023), the closing bid price of the Company’s Class A Common Stock, $0.0001 par value per share (“common stock”) had been below the minimum of $1 per share required for continued listing on the Nasdaq under Nasdaq Rule 5550(a)(2). The Notice stated that the Company would be afforded 180 calendar days (until March 20, 2024) to regain compliance. In order to regain compliance, the closing bid price of the Company’s common stock must be at least $1 for a minimum of ten consecutive business days. The notification lett”

Rein Therapeutics, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 4, 2024, Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company failed to hold its annual meeting of shareholders within twelve (12) months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the “Annual Meeting Listing Rule”). The Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Notice states that the Company has 45 calendar”

Veradigm Inc. received a nasdaq noncompliance notice notice regarding other (rules 5620(a)).

“mpliance (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s not holding an annual meeting of stockholders within the one-year period following its fiscal year ended on December 31, 2022, the Company was not in compliance with Nasdaq Listing Rule 5620(a), which requires companies listing common stock to hold an annual meeting of stockholders no later than one year after the end of the company’s fiscal year (the “Annual Meeting Deficiency”). As previously disclosed, the Company has received prior notices of noncompliance from Nasdaq relating”

REPUBLIC AIRWAYS HOLDINGS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“January 4, 2024, Mesa Air Group, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the period ended September 30, 2023 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The filing delay is not the result of a forthcoming restatement of the”

bleuacacia ltd received a nasdaq compliance regained notice regarding market value (rules 5450(b)(2)(A)).

“d with the SEC on July 10, 2023, the Company had received written notice dated July 5, 2023 from the Staff that it was not then in compliance with a continued listing requirement of the Nasdaq Global Market to maintain a minimum Market Value of Listed Securities as set forth in Nasdaq Listing Rule 5450(b)(2)(A). Upon the transfer of the listing of the Company’s securities to the Nasdaq Capital Market, however, this deficiency will be resolved because the Company will no longer be subject to the continued listing requirements for The Nasdaq Global Market. SIGNATURE Pursuant to the requirement”

Momentus Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 3, 2024, Momentus Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the “Annual Meeting Requirement”). The Notice has no immediate impact on the listing of the Company’s common stock on Nasdaq, and the Company’s listing remains fully effective. Under Nasdaq Rules, the Company has 45 calendar days, or until February 20, 2024, to submit a plan to reg”

Triller Group Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“January 3, 2024, AGBA Group Holding Limited (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “Rule”) because the Company has not maintained a minimum Market Value of Listed Securities (“MVLS”) of at least $35 million. The Notice has no immediate effect on the listing or trading of the Company’s securities. The Company has 180 calendar days from the date of the Notice, or until July 1, 2024, to regain compliance. If at”

Atara Biotherapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“January 8, 2024, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Common Stock closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided a period of 180”

Corbus Pharmaceuticals Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of $311,016, as reported in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023, was below the required minimum of $2.5 million, and because, as of November 9,”

Nixxy, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 5, 2024, Recruiter.com Group, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement to hold an annual meeting within twelve months of the Company’s fiscal year end dated December 31, 2022, pursuant to Nasdaq Listing Rule 5620(a) (the “Annual Meeting Requirement”). In accordance with the Nasdaq Listing Rules, the Company has 45 calendar days, or until February 19, 2024, to submit a plan to regain compliance with the An”

BATTALION OIL CORP received a nyse_american deficiency notice notice regarding other (rules 704).

“January 5, 2024, Battalion Oil Corporation (the “ Company ”) received written notice (the “ Notice ”) on behalf of the NYSE American LLC indicating that, since the Company did not have an annual meeting of stockholders for the fiscal year ended December 31, 2022 by December 31, 2023 (the “ 2023 Annual Meeting ”), the Company is not in compliance with its continued listing standards set forth in Section 704 of the NYSE American Company Guide (the “ Company Guide ”). The Company has scheduled its 2023 Annual Meeting to be held on February 7, 2024, at 11:00 a.m., Central Time, at Two Memorial Cit”

Global System Dynamics, Inc. received a nasdaq hearing update notice regarding market value (rules 5550(b)(2)).

“January 2, 2024, Global System Dynamics, Inc., a Delaware corporation (the “Company”), received a decision from the Nasdaq Hearings Panel (the “Panel”) conditionally granting the Company’s request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with minimum market value of listed securities of $35 million, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”), on or before April 1, 2024, and subject to fulfillment of certain other conditions, including the achievement of various interim milestones (the “Panel Decision”)”

GRI Bio, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 22, 2023 from the Staff notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the “Notice”) based on the information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. Nasdaq Listing Rule 5550(b)(1) requires that companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35,000,000 and annual net income of less than $500,000 maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equ”

GRI Bio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“January 5, 2024, GRI Bio, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s common stock was less than $1.00 for the previous 30 consecutive business days. The Letter is in addition to the previously disclosed letter received on November 22, 2023 from the Staff notifying the Company tha”

Polar Power, Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(c)(4)).

“January 5, 2024, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) that due to Mr. Gross’ resignation, the Company is no longer in compliance with Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rule 5605(c)(4), the Company is entitled to a cure period to regain compliance (i) until the earlier of the Company’s next annual shareholders’ meeting or December 18, 2024; or (ii) if the next annual shareholders’ meeting is held before June 17, 2024, then the Company must evidence compliance no later than June 17, 2024. The Company intends to appoint an addit”

REMARK HOLDINGS, INC. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

“January 2, 2024, Remark Holdings, Inc. (“we” or “our”) notified The Nasdaq Stock Market (“Nasdaq”) that we had attempted to hold our 2023 annual meeting of stockholders on December 6, 2023, and December 29, 2023, but we were unable to achieve a quorum to conduct the business of the meeting on those dates. As a result, we did not hold a shareholder meeting within 12 months of the end of our fiscal year ended December 31, 2022 as required by Nasdaq Rule 5620(a). We again attempted to hold the meeting on January 8, 2024, but were unable to achieve quorum and had to adjourn the meeting without bei”

bleuacacia ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“July 5, 2023 from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it was not then in compliance with a continued listing requirement to maintain a minimum Market Value of Listed Securities of $50,000,000, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) and, subject to the Staff’s determination of the Company’s ability to cure such deficiency—either by regaining compliance or by transferring its listed securities to the Nasdaq Capital Market (the “Capital Market”)—within the 180 calendar day compliance period as set forth in Nasdaq Listing”

Empery Digital Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“. On July 5, 2023, Volcon, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) that the market value of its listed securities had been below the minimum $35,000,000 required for continued listing as set forth in Listing Rule 5550(b)(2) (the “Rule”) for the previous 30 consecutive trading days. In accordance with Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until January 2, 2024, to regain compliance with the Rule. As the Company has not regained compliance with the Rule, on January 4, 2024”

Origin Materials, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“January 4, 2024, Origin Materials, Inc. received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying Origin that for the last 30 consecutive business days the bid price of Origin’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450(a)(1). The notification received has no immediate effect on the listing of Origin’s common stock on Nasdaq. In accordance with listing rule 5810(c)(3)(A), Origin has 180 calendar days, or until July 2, 2024, to regain compliance”

Leafly Holdings, Inc. /DE received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“January 3, 2024, the Company received a letter (the "Notice") from Nasdaq's Listing Qualifications Staff ("Staff") confirming that, as a result of Ms. Chandler's resignation, the Company is no longer in compliance with the Audit Committee Rule. The Notice also indicates that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq is providing the Company a cure period to regain compliance as follows: (i) until the earlier of the Company's next annual meeting of stockholders or January 2, 2025; or (ii) if the next annual meeting of stockholders is held before July 1, 2024, then the Company must”

Data Storage Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

“ule 5605(c)(2)(A) of the Nasdaq listing standards. Accordingly, the Company does not meet the requirements of Rule 5605(c)(2)(A)”

NS Wind Down Co., Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“January 4, 2024, the Company received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock (the “Common Stock”) has closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing of the Common Stock, which continues to trade on the Nasdaq Global Market under the symbol “NSTG”. I”

TC BioPharm (Holdings) plc received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“January 2, 2024, the Company received written confirmation from Nasdaq that it has determined that for the last 10 consecutive business days, from December 15, 2023 to December 29, 2023, the closing bid price of the Company’s securities has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.”

Empery Digital Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii), 5810(c)(3)(A)).

“December 26, 2023, Volcon, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) that it had determined that the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days from December 11, 2023 through December 22, 2023. Pursuant to Listing Rule 5810(c)(3)(A)(iii), if during the 180-day compliance period provided by Listing Rule 5810(c)(3)(A), a listed security has a closing bid price of $0.10 or less for ten consecutive trading days, the Staff shall proceed with a Staff delisting de”

Presto Automation Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“December 28, 2023, Presto Automation Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”), because the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share for 30 consecutive business days. The Notice does not impact the listing of the Common Stock on The Nasdaq Global Market at”

Nuburu, Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

“December 28, 2023, Nuburu, Inc. (the “Company”) received notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the shares of the Company’s common stock have been selling for a low price per share for a substantial period of time. The Notice has no immediate effect on the listing or trading of the Company’s securities and the Company’s common stock will continue to trade on the NYSE American under t”

INTELLIGENT BIO SOLUTIONS INC. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“January 2, 2024, to submit a plan to regain compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). On December 15, 2023, the Company submitted a compliance plan to Nasdaq that included a pro forma balance sheet as of October 31, 2023 (the “Balance Sheet”). The Balance Sheet showed that the Company’s stockholders’ equity as of October 31, 2023, was $4,240,629, which was primarily the result of the of a public offering of the Company’s securities that closed on October 4, 2023. The Balance Sheet was also attached to a Current Report on Form 8-K filed b”

Phunware, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(2)(A), 5605(c)(4)).

“January 3, 2024, Phunware, Inc., (the "Company") received a letter (the "Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, as a result of the resignation of Ryan Costello, as previously disclosed, from the Company's board of directors and its audit committee, the Company is not in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rule 5605(c)(2)(A), a listed company must have an audit committee of at least three members, each of whom must be an Independent Director as defined und”

Singularity Future Technology Ltd. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 3, 2024, Singularity Future Technology Ltd. (the “Company”) received a Staff determination letter (the “Letter”) from The Nasdaq Stock Market (“Nasdaq”) notifying the Company of the Staff’s determination to delist the Company’s securities from Nasdaq because of the Company’s failure to regain compliance with the $1 per share bid price requirement required for continued listing on the Nasdaq as set forth in Listing Rule 5550(a)(2) (the “$1 Bid Rule”). Pursuant to the Letter, unless the Company requests an appeal of the Letter, trading of the Company’s common stock will be suspended at t”

Social Leverage Acquisition Corp I received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“d Warrants) (the “Securities”) because it has not regained compliance with the Market Value of Listed Securities (“MVLS”) standard. The market value of the Company’s listed Securities was below the $50,000,000 minimum MVLS requirement for continued listing on Nasdaq Global under Nasdaq Listing Rule 5450(b)(2)(A) (the “MLVS Rule”). As previously reported by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2023, the Staff initially notified the Company on April 3, 2023 that the minimum MVLS for the Company’s Securities were b”

Quadro Acquisition One Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

“December 27, 2023, Quadro Acquisition One Corp., a Cayman Islands exempted company (the “Company”), received a deficiency notice (“Notice”) from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of the resignations of Clifford Tompsett and Leonid Zilber from the board of directors of the Company (the “Board”) and the audit committee and compensation committee of the Board (“Audit Committee” and “Compensation Committee,” respectively) effective November 21, 2023, the Company is no longer in compliance with the continued listing requirements set forth in Nasdaq Listing R”

Claritev Corp received a nyse delisting notice notice regarding other (rules 802.01D).

“common stock, par value $0.0001 per share (the “Common Stock”), at an exercise price of $11.50 per share, and listed to trade on the NYSE under the symbol “MPLN.WS” (the “Warrants”) and (b) immediately suspend trading in the Warrants due to “abnormally low” trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. The Company does not intend to appeal the NYSE’s determination. Trading in the Company’s Common Stock will be unaffected and will continue on the NYSE under the symbol “MPLN”. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, t”

Q32 Bio Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 29, 2023, Homology Medicines, Inc. (the “ Company ” or “ Homology ”) received a letter (the “ Nasdaq Notification ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Price Requirement ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until June 26, 2”

Nemaura Medical Inc. received a nasdaq delisting notice notice regarding other.

“January 3, 2024, Nemaura Medical Inc. (the “Company”) issued a press release providing a crucial update regarding recent decisions that will impact the Company's listing status on The Nasdaq Capital Market and its broader strategic direction. Among other things, the press release indicated that, after thorough analysis, the Company’s Board of Directors and its management team have made the strategic decision to accept Nasdaq’s determination to delist the Company and move to the OTC Markets. Subsequently, on January 3, 2024, the Company received written notice from Nasdaq indicating that the Na”

ALPINE 4 HOLDINGS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 27, 2023, Alpine 4 Holdings, Inc., a Delaware corporation (the “Company”), received a notice (the “December Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company's Class A Common Stock (the "Common Stock") was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Notice has no immediate impact on the listing of the Company’s Common Stock, which will con”

CEMTREX INC received a nasdaq hearing update notice regarding minimum bid price (rules 5555(a)(1)).

“January 3, 2024, the Company received a letter from The Nasdaq Stock Market LLC’s Hearings Panel notifying the Company that it has made the following amendments to the exception granted on September 8, 2023. ● On January 8, 2024, the Company’s Series 1 Preferred Stock shall close at a minimum bid price of at least $1 per share and maintain such closing bid price for a minimum of ten consecutive business days; ● 2. On January 22, 2024, the Company shall have demonstrated compliance with Listing Rule 5555(a)(1), by evidencing a closing bid price of $1 or more per share for a minimum of ten c”

STRATA Skin Sciences, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“December 27, 2023, the Company received further notification from NASDAQ that the Company had been granted a 180 day extension to June 24, 2024 to regain compliance with the minimum bid price requirement. The Company will regain compliance if the closing bid price of its common stock is $1.00 per share or higher for a minimum period of ten consecutive business days during this compliance period, as confirmed by written notification from NASDAQ. If the Company does not achieve compliance by June 24, 2024, the Company may file an appeal to Nasdaq’s Hearing Panel with a plan to resolve the bid”

SMITH MICRO SOFTWARE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 27, 2023, Smith Micro Software, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (“Nasdaq”) indicating that as result of the closing bid price of the Company’s common stock (“Common Stock”) for the last 30 consecutive business days having been below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) the Company was not in compliance with the Minimum Bid Price Requirement (the “Minimum Bid Price Notice”). The Min”

TOFUTTI BRANDS INC received a otc deficiency notice notice regarding other.

“May 22, 2023 the Registrant received a notice from the OTC Markets Group indicating that the Registrant no longer meets the Standards for Continued Qualification for the OTCQX U.S. tier as per the OTCX Rules for U.S. Companies (Version 8.6) section 3.2.b.2. The Registrant was unable to regain compliance with the Standards for Continued Qualification for the OTCQX U.S. tier. The Registrant transferred to the OTCQB market effective January 2, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf”

Iris Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4)).

“December 26, 2023, from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it no longer meets the minimum 500,000 publicly held shares requirement for The Nasdaq Capital Market, it no longer complies with Listing Rule 5550(a)(4) (the “Rule”) of Nasdaq’s Listing Rules (the “Rules”) for continued listing. In accordance with the Rule, the Company has 45 calendar days to submit a plan to regain compliance. The Company is evaluating various courses of action to achieve compliance with the Rule.”

ID Auto, Inc. received a nyse_american delisting notice notice regarding other (rules 1003(c)(iii)).

“of NYSE Regulation, Inc. (“NYSE Regulation”) notifying the Company that, in light of the Bankruptcy Petitions, the NYSE Regulation has determined that the Company’s Class A common stock (the “Securities”) is no longer suitable for listing and will commence delisting proceedings pursuant to Section 1003(c)(iii) of the NYSE American Company Guide. The Company may appeal the determination pursuant to Part 12 of the NYSE American Company Guide within seven calendar days of the Delisting Notice. However, the Company does not intend to appeal this determination, and, therefore, it is expected that”

Imunon, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 26, 2023, Imunon, Inc. (“the Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) providing notification that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market, which continues to trade under the symbol “IMNN”. In accordance with Nasdaq Listi”